A recap of the top videos and podcasts from Contemporary OB/GYN in September 2026, featuring expert interviews on salpingectomy, testosterone evidence, and more.
|Podcasts|August 19, 2020
S2E2: Overcoming Racism and Unconscious Bias in OB/GYN
Author(s)Contemporary OB/GYN Staff
Senior Editor Angie DeRosa and Associate Editor Lindsey Carr sat down with Drs. Vanessa Rogers and Shawna Nesbitt to discuss racism and unconscious bias in ob/gyn practice.
Advertisement
In this episode of Pap Talk, Senior Editor Angie DeRosa and Associate Editor Lindsey Carr sat down with Drs. Vanessa Rogers and Shawna Nesbitt to discuss racism and unconscious bias in ob/gyn practice.
Read their full feature article from Contemporary OB/GYN: Overcoming racism and unconscious bias in ob/gyn
Watch: Full video interview
Advertisement
Related to this article
A recap of the top headlines from Contemporary OB/GYN in September 2026, spanning ACOG's respiratory vaccine guidance to the launch of the Missed & Dismissed podcast.
Experts discuss common patient concerns about vaccination in pregnancy and strategies to improve uptake.
Experts discuss how obstetric and pediatric clinicians can coordinate to protect newborns.
Experts review ACOG's 2026-27 guidance and the RSV window extension for pregnant and postpartum patients.
On September 9, 2026, certolizumab pegol received FDA Breakthrough Therapy Designation for APS pregnancy; Jane E. Salmon, MD, reviews the IMPACT trial results behind it.
Garima Sharma, MD, outlines validated cardiac risk scores for antenatal screening and the postpartum transitions needed to keep high-risk patients from being lost to follow-up.
Anti-CGRP antibody exposure in early pregnancy was linked to higher spontaneous abortion risk; propranolol was not.
Advertisement
Advertisement